EGF and bFGF promote invasion that is modulated by PI3/akt kinase and erk in vestibular schwannoma

Otology and Neurotology

Volumn 32, Issue 2, 2011, Pages 308-314

  Blair, Katherine J ^a   Kiang, Alan ^a   Wang Rodriguez, Jessica ^b   Yu, Michael Andrew ^a   Doherty, Joni K ^a   Ongkeko, Weg M ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acoustic neuroma; Akt; BFGF; EGFR; Epidermal growth factor receptor; EPO; EPOR; ErbB 1; Erk; Erythropoietin; FGF2; Fibroblast growth factor; MAP kinase; PI3 kinase; Tyrosine kinase; Vestibular schwannoma

Indexed keywords

COLLAGEN; EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; GELATINASE B; LAMININ; MATRIGEL; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; PROTEOGLYCAN;

ARTICLE; BIOSYNTHESIS; CANCER INVASION; DRUG ANTAGONISM; DRUG COMBINATION; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; NEUROMA; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; COLLAGEN; DRUG COMBINATIONS; EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLAST GROWTH FACTOR 2; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEUROMA, ACOUSTIC; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 79955671148     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e318206fc3d     Document Type: Article

References (37)

1. Feghali JG, Kantrowitz AB. Atypical invasion of the temporal bone in vestibular schwannoma. Skull Base Surg 1995; 5: 33-6.
2. Linthicum FH Jr, Brackmann DE. Bilateral acoustic tumors. A diagnostic and surgical challenge. Arch Otolaryngol 1980; 106: 729-33.
3. Matsunaga T, Hosoda Y, Kanzaki J. Ultrastructural localization of nerve growth factor receptor in acoustic neurinoma. Acta Otolaryngol Suppl 1991; 487: 69-74.
4. Cardillo MR, Filipo R, Monini S, et al. Transforming growth factor-beta1 expression in human acoustic neuroma. Am J Otol 1999; 20: 65-8.
5. O'Reilly BF, Kishore A, Crowther JA, et al. Correlation of growth factor receptor expression with clinical growth in vestibular schwannomas. Otol Neurotol 2004; 25: 791-6.
6. Sturgis EM, Woll SS, Aydin F, et al. Epidermal growth factor receptor expression by acoustic neuromas. Laryngoscope 1996; 106: 457-62.
7. Doherty JK, Ongkeko W, Crawley B, et al. ErbB and Nrg: potential molecular targets for vestibular schwannoma pharmacotherapy. Otol Neurotol 2008; 29: 50-7.
8. Unlu A, Leake RE. The effect of EGFR-related tyrosine kinase activity inhibition on the growth and invasion mechanisms of prostate carcinoma cell lines. Int J Biol Markers 2003; 18: 139-46.
9. Festuccia C, Angelucci A, Gravina GL, et al. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinasetype plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination. Thromb Haemost 2005; 93: 964-75.
10. Dillard DG, Venkatraman G, Cohen C, et al. Immunolocalization of erythropoietin and erythropoietin receptor in vestibular schwannoma. Acta Otolaryngol 2001; 121: 149-52.
11. Oda K, Matsuoka Y, Funahashi A, et al. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol 2005; 1: 2005.0010.
12. Downward J, Parker P, Waterfield MD. Autophosphorylation sites on the epidermal growth factor receptor. Nature 1984; 311: 483-5.
13. Jacob A, Lee TX, Neff BA, et al. Phosphatidylinositol 3-kinase/ AKT pathway activation in human vestibular schwannoma. Otol Neurotol 2008; 29: 58-68.
14. Lee TX, Packer MD, Huang J, et al. Growth inhibitory and antitumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells. Eur J Cancer 2009; 45: 1709-20.
15. Tzeng SF, Deibler GE, DeVries GH. Myelin basic protein and myelin basic protein peptides induce the proliferation of Schwann cells via ganglioside GM1 and the FGF receptor. Neurochem Res 1999; 24: 255-60.
16. Bartolami S, Auge C, Travo C, et al. Vestibular Schwann cells are a distinct subpopulation of peripheral glia with specific sensitivity to growth factors and extracellular matrix components. J Neurobiol 2003; 57: 270-90.
17. Koutsimpelas D, Stripf T, Heinrich UR, et al. Expression of vascular endothelial growth factor and basic fibroblast growth factor in sporadic vestibular schwannomas correlates to growth characteristics. Otol Neurotol 2007; 28: 1094-9.
18. Sahadevan K, Darby S, Leung HY, et al. Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer. J Pathol 2007; 213: 82-90.
19. Ruohola JK, Viitanen TP, Valve EM, et al. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells. Cancer Res 2001; 61: 4229-37.
20. Suyama K, Shapiro I, Guttman M, et al. A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2002; 2: 301-14.
21. Nomura S, Yoshitomi H, Takano S, et al. FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer. Br J Cancer 2008; 99: 305-13.
22. Niu J, Chang Z, Peng B, et al. Keratinocyte growth factor/fibroblast growth factor-7-regulated cell migration and invasion through activation of NF-kappaB transcription factors. J Biol Chem 2007; 282: 6001-11.
23. Miyake H, Yoshimura K, Hara I, et al. Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines. J Urol 1997; 157: 2351-5.
24. Diensthuber M, Ilner T, Rodt T, et al. Erythropoietin and eryth-ropoietin receptor expression in vestibular schwannoma: potential role in tumor progression. Otol Neurotol 2007; 28: 559-65.
25. Hardee ME, Arcasoy MO, Blackwell KL, et al. Erythropoietin biology in cancer. Clin Cancer Res 2006; 12: 332-9.
26. Leyland-Jones B. Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol 2003; 4: 459-60.
27. Henke M, Laszig R, Rube C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003; 362: 1255-60.
28. Lai SY, Childs EE, Xi S, et al. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene 2005; 24: 4442-9.
29. Mohyeldin A, Lu H, Dalgard C, et al. Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. Neoplasia 2005; 7: 537-43.
30. Silva M, Grillot D, Benito A, et al. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 1996; 88: 1576-82.
31. Schlessinger J. Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 2004; 306: 1506-7.
32. Fernandis AZ, Prasad A, Band H, et al. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 2004; 23: 157-67.
33. Curto M, Cole BK, Lallemand D, et al. Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J Cell Biol 2007; 177: 893-903.
34. Werner JA, Rathcke IO, Mandic R. The role of matrix metallo-proteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis 2002; 19: 275-82.
35. Falcioni M, Taibah A, Di Trapani G, et al. Inner ear extension of vestibular schwannomas. Laryngoscope 2003; 113: 1605-8.
36. Forton GE, Cremers CW, Offeciers EE. Acoustic neuroma ingrowth in the cochlear nerve: does it influence the clinical presentation? Ann Otol Rhinol Laryngol 2004; 113: 582-6.
37. Clark JJ, Provenzano M, Diggelmann HR, et al. The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study. Otol Neurotol 2008; 29: 846-53.